Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $17.62 USD
Change Today -0.19 / -1.07%
Volume 208.6K
PETX On Other Exchanges
Symbol
Exchange
NASDAQ GM
Stuttgart
As of 8:10 PM 07/31/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Steven St. Peter M.D.

Co-Founder, Chief Executive Officer, President and Director, Aratana Therapeutics, Inc.
AgeTotal Calculated CompensationThis person is connected to 31 board members in 3 different organizations across 12 different industries.

See Board Relationships
49$7,872,182
As of Fiscal Year 2014

Background*

Dr. Steven St. Peter, M.D., is a Co-Founder of Aratana Therapeutics, Inc., and has been its Chief Executive Officer and President since September 6, 2012. Dr. St. Peter served as the Managing Director of MPM Capital until May 2012, which he joined MPM Capital in 2003. He started working at the MPM in 2004 and was promoted to a General Partner in 2005. He served as a Principal of the MPM. His investment scope included both venture and buyout transactions across the pharmaceuticals ...

Read Full Background

Corporate Headquarters*

1901 Olathe Boulevard
Kansas City, Kansas 66103

United States

Phone: 913-353-1000
Fax: 913-904-9641

Board Members Memberships*

Director
2007-Present
Independent Director and Member of Governance & Nominating Committee
2010-Present
Co-Founder, Chief Executive Officer, President and Director

Education*

MD
Washington University, St. Louis
BA
University of Kansas
MBA
University of Pennsylvania - The Wharton School

Other Affiliations*

Annual Compensation*

Salary$467,500
Total Annual Compensation$467,500

Stock Options*

Restricted Stock Awards$4,144,500
All Other Compensation$10,400
Exercisable Options31,396
Exercisable Options Value$371,101
Unexercisable Options319,025
Unexercisable Options Value$1,111,376
Total Value of Options$1,482,476
Total Number of Options350,421

Total Compensation*

Total Annual Cash Compensation$699,963
Total Short Term Compensation$467,500
Other Long Term Compensation$4,154,900
Total Calculated Compensation$7,872,182
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
PETX:US $17.62 USD -0.19

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Richard Chin M.D.Co-Founder, Chief Executive Officer, President and Director
Kindred Biosciences, Inc.
$495.5K
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ARATANA THERAPEUTICS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.